Cargando…

Bilateral Refractive Changes in Vascularized Pigment Epithelial Detachment Treated by Anti-VEGF Therapy

We report the case of a patient bilaterally treated with anti-VEGF compounds for bilateral massive vascularized retinal pigment epithelial detachment (PED). During the years prior to treatment, PED growth was accompanied by gradual hypermetropization. After right intraocular injection of bevacizumab...

Descripción completa

Detalles Bibliográficos
Autores principales: Hanhart, Joel, Chowers, Itay
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4777956/
https://www.ncbi.nlm.nih.gov/pubmed/26955349
http://dx.doi.org/10.1159/000442789
_version_ 1782419376902766592
author Hanhart, Joel
Chowers, Itay
author_facet Hanhart, Joel
Chowers, Itay
author_sort Hanhart, Joel
collection PubMed
description We report the case of a patient bilaterally treated with anti-VEGF compounds for bilateral massive vascularized retinal pigment epithelial detachment (PED). During the years prior to treatment, PED growth was accompanied by gradual hypermetropization. After right intraocular injection of bevacizumab followed by three bilateral aflibercept injections, the PED flattened resulting in a rapid relative myopization. This case illustrates ocular refractive properties associated with PED and its response to treatment. This case also highlights the importance of assessing refraction in age-related macular degeneration patients experiencing substantial PED amplitude changes.
format Online
Article
Text
id pubmed-4777956
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher S. Karger AG
record_format MEDLINE/PubMed
spelling pubmed-47779562016-03-07 Bilateral Refractive Changes in Vascularized Pigment Epithelial Detachment Treated by Anti-VEGF Therapy Hanhart, Joel Chowers, Itay Case Rep Ophthalmol Published online: December, 2015 We report the case of a patient bilaterally treated with anti-VEGF compounds for bilateral massive vascularized retinal pigment epithelial detachment (PED). During the years prior to treatment, PED growth was accompanied by gradual hypermetropization. After right intraocular injection of bevacizumab followed by three bilateral aflibercept injections, the PED flattened resulting in a rapid relative myopization. This case illustrates ocular refractive properties associated with PED and its response to treatment. This case also highlights the importance of assessing refraction in age-related macular degeneration patients experiencing substantial PED amplitude changes. S. Karger AG 2015-12-19 /pmc/articles/PMC4777956/ /pubmed/26955349 http://dx.doi.org/10.1159/000442789 Text en Copyright © 2015 by S. Karger AG, Basel http://creativecommons.org/licenses/by-nc/4.0/ This article is licensed under the Creative Commons Attribution-NonCommercial-4.0 International License (CC BY-NC) (http://www.karger.com/Services/OpenAccessLicense). Usage and distribution for commercial purposes requires written permission.
spellingShingle Published online: December, 2015
Hanhart, Joel
Chowers, Itay
Bilateral Refractive Changes in Vascularized Pigment Epithelial Detachment Treated by Anti-VEGF Therapy
title Bilateral Refractive Changes in Vascularized Pigment Epithelial Detachment Treated by Anti-VEGF Therapy
title_full Bilateral Refractive Changes in Vascularized Pigment Epithelial Detachment Treated by Anti-VEGF Therapy
title_fullStr Bilateral Refractive Changes in Vascularized Pigment Epithelial Detachment Treated by Anti-VEGF Therapy
title_full_unstemmed Bilateral Refractive Changes in Vascularized Pigment Epithelial Detachment Treated by Anti-VEGF Therapy
title_short Bilateral Refractive Changes in Vascularized Pigment Epithelial Detachment Treated by Anti-VEGF Therapy
title_sort bilateral refractive changes in vascularized pigment epithelial detachment treated by anti-vegf therapy
topic Published online: December, 2015
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4777956/
https://www.ncbi.nlm.nih.gov/pubmed/26955349
http://dx.doi.org/10.1159/000442789
work_keys_str_mv AT hanhartjoel bilateralrefractivechangesinvascularizedpigmentepithelialdetachmenttreatedbyantivegftherapy
AT chowersitay bilateralrefractivechangesinvascularizedpigmentepithelialdetachmenttreatedbyantivegftherapy